Clinical Trial Update: Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Completed Phase 1 trial assessing a repeated dosing regimen of a new insulin glargine formulation in combination with Lantus (insulin glargine) in people with T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (new formulation) (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED